Introduction
Gitelman syndrome is an autosomal recessive disease characterized by hypokalemic metabolic alkalosis, hypomagnesemia, and hypocalciuria 1) . This disorder is caused by mutation in the SLC12A3 gene, which encodes the thiazide-sensitive NaCl cotransporter (NCCT). Acquired renal tubular disorder can be observed in various disease processes, especially autoimmune diseases [2] [3] [4] [5] [6] [7] [8] [9] [10] . Acquired Gitelman syndrome associated with autoimmune disease is rare and four cases have been reported in the medical literature 8, [10] [11] [12] . The mechanism underlying acquired Gitelman syndrome associated with autoimmune disease is not clear.
Recently, the presence of circulating auto-antibodies against NCCT in a patient with autoimmune disease was reported 8) .
In this review article, we will summarize the acquired Gitelman syndrome associated with autoimmune disease and discuss the presence of circulating auto-antibodies against tubular transporter as a mechanism of acquired renal tubular disorders.
Inherited Gitelman syndrome
Inherited Gitelman syndrome is caused by mutations in SLC12A3 gene encoding NCCT 13) . NCCT is expressed at the apical membrane of the distal convoluted tubule (DCT), and loss-of-function mutation in NCCT leads to disruption of Na + and Cl reabsorption in the DCT. Decreased Na In three of four patients, the leading symptoms were , AE1
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Intercalated cell 4) Loop of Henle 5) Cortical collecting duct 6) Collecting duct 7) Gitelman syndrome Sjögren's syndrome Renal transplantation NCCT 8) Donor NCCT 9) Bartter syndrome Sjögren's syndrome NKCC2 10) AE1, anion exchanger 1; NCCT, thiazide-sensitive NaCl cotransporter; NKCC2, sodium-chloride-potassium cotransporter.
Table 2. Review of Acquired Gitelman Syndrome in Sjögren's Syndrome
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Kim et al. patients, serum potassium and magnesium levels were improved and clinical symptoms were attenuated with supplement of potassium and/or magnesium. Steroid treatment was done in three patients and was effective in two patients 8, 10) . The prognosis of acquire Gitelman syndrome with primary Sjögren's syndrome may be good. In three of four patients, normokalemia was maintained during the follow-up period. No patient had renal insufficiency or relapse. 
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